Carbognin, L., Pilotto, S., Milella, M., Vaccaro, V., Brunelli, M., Caliò, A., . . . Tortora, G. (2015). Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers. PLoS One.
Citação norma ChicagoCarbognin, Luisa, et al. "Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A According to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers." PLoS One 2015.
Citação norma MLACarbognin, Luisa, et al. "Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A According to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers." PLoS One 2015.